RUNDC3A-AS1 is an adverse prognostic factor for triple-negative breast cancer which mediates the Warburg effect and Adriamycin resistance by targeting miR-224-3p/COL5A2

Toxicology and Applied Pharmacology 2026

View at publisher

Authors: Linna Kong, Xiaoyan Liu, Huihui Zhang, Jiaqi Liu

DOI: 10.1016/j.taap.2026.117776

Cited by: 0

References: 31

Fields of Study & Subjects

Cancer-related molecular mechanisms research MicroRNA in disease regulation RNA modifications and cancer

References 31